Valuation: GC Genome Corporation

Market Cap 129B 91.24M 78.99M 73.83M 67.48M 127M 8.7B 129M 866M 340M 4.35B 343M 335M 14.5B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 69.97M 49.35K 42.72K 39.93K 36.49K 68.77K 4.71M 69.85K 468K 184K 2.35M 185K 181K 7.84M EV / Sales 2026 *
1.79x
EV / Sales 2027 * 1.24x
Free-Float
49.55%
Yield 2026 *
-
Yield 2027 * -
1 day+4.59%
1 week+18.91%
Current month+18.91%
1 month+20.88%
3 months-26.38%
6 months-38.47%
Current year-19.79%
1 week 4,865
Extreme 4865
5,470
1 month 4,100
Extreme 4100
5,470
Current year 4,100
Extreme 4100
9,520
1 year 4,100
Extreme 4100
9,520
3 years 4,100
Extreme 4100
15,180
5 years 4,100
Extreme 4100
15,180
10 years 4,100
Extreme 4100
15,180
Manager TitleAgeSince
Chief Executive Officer 57 26/03/2020
Director of Finance/CFO 50 27/03/2025
Comptroller/Controller/Auditor 45 29/03/2024
Director TitleAgeSince
Director/Board Member 57 30/03/2023
Date Insider Type Main position Quantity % Market Cap.
17/6/25 Free

Chief Executive Officer

169,285 -
17/6/25 Free 138,250 -
Change 5-day change 1-year change 3-year change Capi.($)
+4.59%+18.91%-32.22% - 87.76M
+0.00%+17.77%+102.75%+496.93% 46.43B
+0.28%+3.66%+19.05%+48.90% 25.88B
+0.67%+2.47%-19.02%-34.52% 7.76B
+6.37%+14.56%+23.43%+139.82% 5.69B
+1.16%+2.56%+22.50%+63.98% 3.39B
+1.53%+14.05%-29.98%+1,354.79% 2.3B
-0.18%+4.70%+184.97%+17.58% 2.13B
+6.83%+11.49%+2.48%-53.01% 1.99B
+4.04%+15.84%+33.80%-8.80% 1.84B
Average +2.37%+10.12%+30.78%+225.07% 9.75B
Weighted average by Cap. +0.25%+12.65%+58.61%+288.58%

Financials

2026 *2027 *
Net sales 39B 27.51M 23.81M 22.26M 20.34M 38.33M 2.62B 38.93M 261M 102M 1.31B 103M 101M 4.37B 48.8B 34.42M 29.8M 27.85M 25.45M 47.96M 3.28B 48.71M 327M 128M 1.64B 129M 126M 5.47B
Net income - -
Net Debt -59.4B -41.89M -36.27M -33.9M -30.98M -58.38M -4B -59.3M -398M -156M -2B -157M -154M -6.66B -68.8B -48.52M -42.01M -39.26M -35.88M -67.62M -4.63B -68.68M -460M -181M -2.32B -182M -178M -7.71B
Logo GC Genome Corporation
GC Genome Corp is a Korea-based company principally engaged in the provision of genome testing and analysis services. The Company is principally engaged in the provision of prenatal and newborn screening genetic testing services, cancer patient precision diagnosis genetic testing services, precision diagnosis genetic testing service for patients with rare diseases, health checkup test services as well as others.
Employees
-
Date Price Change Volume
10/08/26 KRW 5,470.00 +4.59% 128,036
07/08/26 KRW 5,230.00 -0.19% 29,666
06/08/26 KRW 5,240.00 +0.19% 37,983
05/08/26 KRW 5,230.00 +2.55% 135,985
04/08/26 KRW 5,100.00 +4.83% 133,142

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. A340450 Stock